News

Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain
Lonza expands DNA-to-IND offering to accelerate biologics development timelines
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
AstraZeneca highlights long-term remission and steroid-sparing data for Saphnelo at EULAR 2026
read more
Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics
Society for RNA Therapeutics expands leadership team
read more
Advanced Therapies,Clinical & Regulatory,Therapeutic Areas
CuraCell reports pancreatic cancer findings from personalised TIL therapy programme
read more
Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics
Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development
Apoha raises $36M to expand molecular behaviour data platform
read more
Advanced Therapies,Drug Discovery & Development,Medical devices
Crowdhelix launches regenerative medicine network to support bioprinted cornea research
read more
Clinical & Regulatory,Opinion & Events,Therapeutic Areas
World Bronchiectasis Conference returns to Hannover after decade of progress
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development
Ingenix raises €13M to expand AI platform for drug development
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Evogene reports Phase 1 results for microbiome therapy BMC128 with nivolumab
read more
Biotech & Pharma Business,Digital & Data
IMU Biosciences extends Series A to $53M to advance immune profiling platform
read more
Biotech & Pharma Business,Medical devices
LotusDx opens Aberdeen R&D laboratory to advance at-home STI testing
read more
Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development
Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Phase 3 data support PSMA-targeted radiopharmaceutical combination approach in advanced prostate cancer
read more
Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Bruker launches new proteomics and metabolomics platforms at ASMS 2026
read more
Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain
Thermo Fisher expands Orbitrap mass spectrometry portfolio with new AI-enabled platforms at ASMS 2026
read more

Lonza expands DNA-to-IND offering to accelerate biologics development timelines

AstraZeneca highlights long-term remission and steroid-sparing data for Saphnelo at EULAR 2026

Society for RNA Therapeutics expands leadership team

CuraCell reports pancreatic cancer findings from personalised TIL therapy programme

Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology

Apoha raises $36M to expand molecular behaviour data platform

Crowdhelix launches regenerative medicine network to support bioprinted cornea research

World Bronchiectasis Conference returns to Hannover after decade of progress

Ingenix raises €13M to expand AI platform for drug development

Evogene reports Phase 1 results for microbiome therapy BMC128 with nivolumab

IMU Biosciences extends Series A to $53M to advance immune profiling platform

LotusDx opens Aberdeen R&D laboratory to advance at-home STI testing

Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge

Phase 3 data support PSMA-targeted radiopharmaceutical combination approach in advanced prostate cancer

Bruker launches new proteomics and metabolomics platforms at ASMS 2026

Thermo Fisher expands Orbitrap mass spectrometry portfolio with new AI-enabled platforms at ASMS 2026

main menu

recent posts

EnteroBiotix doses first patient in Phase 2b IBS-C microbiome trial

bit.bio launches cell culture media kits for human cell research

Cyllene Therapeutics raises €33M to advance EG110A into late-stage development

get connected